Breast Cancer Therapeutics
Europe
Updated
Reviewed by Chandani Patel
Europe Skin Boosters Market Industry Trends and Forecast to 2034: Segmented by (Product, Area, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$349.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $210.9 Mn | — | — |
| 2025 (base) | $233.4 Mn | +$22.6 Mn | — |
| 2026 (forecast) | $258.4 Mn | +$25.0 Mn | +10.7% |
| 2027 (forecast) | $286.1 Mn | +$27.7 Mn | +22.5% |
| 2028 (forecast) | $316.7 Mn | +$30.6 Mn | +35.7% |
| 2029 (forecast) | $350.6 Mn | +$33.9 Mn | +50.2% |
| 2030 (forecast) | $388.1 Mn | +$37.5 Mn | +66.2% |
| 2031 (forecast) | $429.6 Mn | +$41.5 Mn | +84% |
| 2032 (forecast) | $475.6 Mn | +$46.0 Mn | +103.7% |
| 2033 (forecast) | $526.5 Mn | +$50.9 Mn | +125.5% |
| 2034 (forecast) | $582.8 Mn | +$56.3 Mn | +149.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $233.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $582.8 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, area and end user (see all) |
| Key players | Galderma S.A., Allergan, Teoxane, Croma Pharma, Mastelli (see all) |
| Regulator in Europe | EMASource: European Medicines Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Skin boosters are injectable treatments, often hyaluronic acid, that hydrate and improve skin quality rather than add volume.
Key segments of the skin Boosters market include product (Hyaluronic Acid Boosters, Polynucleotides and Exosome Boosters) and area (Face, Neck and Hands).
Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the skin Boosters market. More clinics and chains are opening in fast-growing cities.
Treatments for men, at-home options, digital consultations and growth in Asia and the Middle East give the skin Boosters market room to grow.
Treatments are mostly paid out of pocket, results and safety vary between providers, and economic slowdowns can reduce spending on the skin Boosters market.
The skin Boosters market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).[1] In the countries we cover here, medicines are approved by ANSM (France)[2], BfArM (Germany)[3], AIFA (Italy)[4], Ministry of Health (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8]
[1] European Medicines Agency. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Commission, health technology assessment. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for skin Boosters. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Europe.
What doctors and scientists are doing in Skin Boosters right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe
Europe
Europe
Europe
Europe
Europe
Medical Devices · Europe
Digital Health · Europe
Healthcare Services · Europe
OTC & Nutraceuticals · Europe
OTC & Nutraceuticals · Europe
Medical Devices · Europe